Doctor Profile
Dr. Jinsong Lu
Breast Oncology
Professor · Chief Physician · Doctoral Supervisor · MD
Breast Oncology Expert
Breast Cancer
Breast Reconstruction
30+ yrs
Experience
60+
International Academic Papers
15+
SCI Papers
Expertise
Dr. Lu specializes in frontline clinical work and research on breast cancer. He has extensive clinical experience, especially in areas such as early detection, early diagnosis, and early surgical treatment of breast cancer; optimized neoadjuvant comprehensive treatment before surgery for locally advanced breast cancer that cannot be directly operated on, followed by surgical treatment after tumor shrinkage; and optimized comprehensive treatments like postoperative adjuvant chemotherapy, endocrine therapy, and targeted therapy to improve treatment efficacy and prevent recurrence and metastasis.
Professional Background
For over 30 years, Dr. Lu has been dedicated to the early diagnosis of breast cancer and comprehensive treatment centered on surgical therapy. From 1995 to 2000, he studied at the Cancer Hospital of Shanghai Medical University, where he pursued a doctoral degree in surgical oncology under the mentorship of Professor Shen Zhenzhou, a renowned expert in breast cancer in China. In 1998, he went to the Karmanos Cancer Institute of the Detroit Medical Center in the United States for further studies. In recent years, he has published 16 SCI papers related to clinical and basic research on breast cancer internationally as corresponding author, first author, and co-first author.
Awards & Honors
Third Prize of the Chinese Medical Science and Technology Award
Second Prize of the Shanghai Science and Technology Progress Award
Second Prize of the Shanghai Medical Science and Technology Award
Recipient of the “Model of Medical Ethics” Award, Shanghai Education and Health System
Recipient of “Top Ten Doctors of Shanghai” Award
Selected for the 2024 “Shanghai Good Doctors” List
Recent Key Publications:
Metronomic paclitaxel and cisplatin chemotherapy for metastatic breast cancer: insights from a target trial emulationLi, Yaorong et al.The Lancet Regional Health – Western Pacific, Volume 55, 101457
Wu, Yifan MDa; Tian, Xinran BSca; Ma, Jiayi MDa; Lin, Yanping MSca; Ye, Jian PhDb,c,d,*; Wang, Yaohui MDa,*; Lu, Jingsong MDa,*; Yin, Wenjin MDa,*. Label-free discrimination analysis of breast cancer tumor and adjacent tissues of patients after neoadjuvant treatment using Raman spectroscopy: a diagnostic study. International Journal of Surgery 111(2):p 1788-1800, February 2025. | DOI: 10.1097/JS9.0000000000002201
Zhu, M., Wu, Q., Geng, X., Xie, H., Wang, Y., Wu, Z., Lin, Y., Zhou, L., Xu, S., Ye, Y., Yin, W., Hua, J., Lu, J., & Wang, Y. (2025). Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After Neoadjuvant Chemotherapy in Breast Cancer. Current Oncology, 32(2), 93. https://doi.org/10.3390/curroncol32020093
Xie, J., Wei, J., Shi, H. et al. A deep learning approach for early prediction of breast cancer neoadjuvant chemotherapy response on multistage bimodal ultrasound images. BMC Med Imaging 25, 26 (2025). https://doi.org/10.1186/s12880-024-01543-7
Ma, J., Wu, Z., Xu, Y., Wang, Y., Lin, Y., Zhou, L., Xu, S., Zhang, J., Yin, W., & Lu, J. (2024). Survival outcomes, multidimensional prediction and subsequent therapy in patients with hormone receptor-positive advanced breast cancer receiving palbociclib: a real-world analysis. Gland Surgery, 13(12), 2313-2324. doi:10.21037/gs-24-362
Contact Us
We would love to speak with you.
Feel free to reach out using the below details.
Find us Here
- +1 8324667523
- services@chinahealthtrip.com
Fill out the form below!
Dr. Jinsong Lu
Breast Oncology
Professor · Chief Physician · Doctoral Supervisor · MD
Breast Oncology Expert
Breast Cancer
Breast Reconstruction
Experience
International Academic Papers
SCI Papers
Expertise
Dr. Lu specializes in frontline clinical work and research on breast cancer. He has extensive clinical experience, especially in areas such as early detection, early diagnosis, and early surgical treatment of breast cancer; optimized neoadjuvant comprehensive treatment before surgery for locally advanced breast cancer that cannot be directly operated on, followed by surgical treatment after tumor shrinkage; and optimized comprehensive treatments like postoperative adjuvant chemotherapy, endocrine therapy, and targeted therapy to improve treatment efficacy and prevent recurrence and metastasis.
Professional Background
For over 30 years, Dr. Lu has been dedicated to the early diagnosis of breast cancer and comprehensive treatment centered on surgical therapy. From 1995 to 2000, he studied at the Cancer Hospital of Shanghai Medical University, where he pursued a doctoral degree in surgical oncology under the mentorship of Professor Shen Zhenzhou, a renowned expert in breast cancer in China. In 1998, he went to the Karmanos Cancer Institute of the Detroit Medical Center in the United States for further studies. In recent years, he has published 16 SCI papers related to clinical and basic research on breast cancer internationally as corresponding author, first author, and co-first author.
Awards & Honors
Third Prize of the Chinese Medical Science and Technology Award
Second Prize of the Shanghai Science and Technology Progress Award
Second Prize of the Shanghai Medical Science and Technology Award
Recipient of the "Model of Medical Ethics" Award, Shanghai Education and Health System
Recipient of "Top Ten Doctors of Shanghai" Award
Selected for the 2024 "Shanghai Good Doctors" List
Professional Background
Contact Us
We would love to speak with you.
Feel free to reach out using the below details.
Find us Here
- +1 8324667523
- services@chinahealthtrip.com